2-Methacryloyloxyethyl phosphorylcholine (MPC)-polymer suppresses an increase of oral bacteria: a single-blind, crossover clinical trial
Related Experiment Video
Updated: Feb 10, 2026

2-Methacryloyloxyethyl Phosphorylcholine Polymer Treatment of Complete Dentures to Inhibit Denture Plaque Deposition
Published on: December 26, 2016
Natsumi Fujiwara1,2, Hiromichi Yumoto3, Koji Miyamoto4
1Department of Oral Microbiology, Tokushima University Graduate School of Biomedical Sciences, 3-18-15 Kuramoto-cho, Tokushima, Tokushima, 770-8504, Japan. nfujiwara@tokushima-u.ac.jp.
Objectives:
The biocompatible 2-methacryloyloxyethyl phosphorylcholine (MPC)-polymers, which mimic a biomembrane, reduce protein adsorption and bacterial adhesion and inhibit cell attachment. The aim of this study is to clarify whether MPC-polymer can suppress the bacterial adherence in oral cavity by a crossover design. We also investigated the number of Fusobacterium nucleatum, which is the key bacterium forming dental plaque, in clinical samples.
Materials And Methods:
This study was a randomized, placebo-controlled, single-blind, crossover study, with two treatment periods separated by a 2-week washout period. We conducted clinical trial with 20 healthy subjects to evaluate the effect of 5% MPC-polymer mouthwash after 5 h on oral microflora. PBS was used as a control. The bacterial number in the gargling sample before and after intervention was counted by an electronic bacterial counter and a culture method. DNA amounts of total bacteria and F. nucleatum were examined by q-PCR.
Results:
The numbers of total bacteria and oral streptcocci after 5 h of 5% MPC-polymer treatment significantly decreased, compared to the control group. Moreover, the DNA amounts of total bacteria and F. nucleatum significantly decreased by 5% MPC-polymer mouthwash.
Conclusions:
We suggest that MPC-polymer coating in the oral cavity may suppress the oral bacterial adherence.
Clinical Relevance:
MPC-polymer can be a potent compound for the control of oral microflora to prevent oral infection.
Insights
2-methacryloyloxyethyl phosphorylcholine (MPC)-polymer mouthwash significantly reduced oral bacteria, including Fusobacterium nucleatum, in a clinical trial. This biomimetic polymer shows potential for controlling oral microflora and preventing infections.
Area of Science:
- Biomaterials Science
- Oral Microbiology
- Polymer Chemistry
Background:
- Biocompatible 2-methacryloyloxyethyl phosphorylcholine (MPC)-polymers mimic biomembranes.
- MPC-polymers are known to reduce protein adsorption and bacterial adhesion.
- Their efficacy in suppressing oral bacterial adherence requires further investigation.
Purpose of the Study:
- To evaluate the effectiveness of a 5% MPC-polymer mouthwash in suppressing bacterial adherence in the oral cavity.
- To investigate the impact of MPC-polymer on the number of Fusobacterium nucleatum, a key dental plaque bacterium.
Main Methods:
- A randomized, placebo-controlled, single-blind, crossover study with 20 healthy subjects.
- Evaluation of a 5% MPC-polymer mouthwash versus a phosphate-buffered saline (PBS) control.
- Bacterial counts determined by electronic counter, culture methods, and quantitative PCR (q-PCR) for total bacteria and F. nucleatum.
Main Results:
- A significant decrease in total bacteria and oral streptococci counts was observed 5 hours post-treatment with MPC-polymer mouthwash compared to the control.
- Quantitative PCR analysis revealed a significant reduction in the DNA amounts of total bacteria and F. nucleatum.
Conclusions:
- MPC-polymer coating in the oral cavity demonstrates potential for suppressing oral bacterial adherence.
- MPC-polymer is a promising compound for managing oral microflora and preventing oral infections.
Related Concept Videos
Clinical Trials
There are four phases in a clinical trial. A phase one...
Clinical Trials: Overview
Blind Procedures
Statistical Software for Data Analysis and Clinical Trials
Polymers
Blinding

